Clinical Trial Update: Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

View source ↗

Summary

Clinical trial evaluating tamoxifen in women with breast cancer and in women at high risk who are taking certain antidepressants or gabapentin, focusing on pote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Major Depressive Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)
• Escitalopram (escitalopram)
• Gabapentin (Gabapentin)
• Sertraline (Sertraline)
• Tamoxifen (tamoxifen)
• Venlafaxine (Venlafaxine)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer, Depression | Status: COMPLETED